The future is here—targeted therapies are coming of age in biliary tract cancers
Chinese Clinical Oncology · 2023
DOI: 10.21037/cco-23-20 ↗Kurz gefasst
Editorial in der Zeitschrift Chinese Clinical Oncology, 2023. Verfasst von Daniel Neureiter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (SALK), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Aust…. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pathology, Paracelsus Medical University/University Hospital Salzburg (SALK), Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria.
- Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Campus Charité Mitte, Charité University Medicine Berlin, Berlin, Germany; EO Translational Insights Consulting GmbH, Berlin, Germany.
Zitieren
APA
Neureiter, D., & Ocker, M. (2023). The future is here—targeted therapies are coming of age in biliary tract cancers. Chinese Clinical Oncology. https://doi.org/10.21037/cco-23-20
Vancouver
Neureiter D, Ocker M. The future is here—targeted therapies are coming of age in biliary tract cancers. Chinese Clinical Oncology. 2023. doi:10.21037/cco-23-20
BibTeX
@article{Neureiter2023,
author = {Neureiter, Daniel and Ocker, Matthias},
title = {The future is here—targeted therapies are coming of age in biliary tract cancers},
journal = {Chinese Clinical Oncology},
year = {2023},
doi = {10.21037/cco-23-20}
}
EUVIMED